NCBiotech Jobs Board ● Connecting North Carolina's life science employers and workforce.

IMMvention Therapeutix is a privately funded Research Triangle, NC based biotechnology company. We are focused on improving the lives of patients with inflammatory/rheumatic diseases of huge unmet needs (such as Rheumatoid Arthritis, Osteoarthritis, Gout, Alzheimer’s etc.). The company is discovering and developing first-in-class novel disease modifying small molecule therapies that inhibit the inflammation caused by activation of inflammasomes. The company’s differentiation is its novel product pipeline powered by the intellectual capital of its team and a platform to discover small molecule inhibitors of inflammasomes.

The company was co-founded in 2017 by pioneering scientists in the fields of immunology and innate immunity. This includes Dr. Jenny Ting, who is a preeminent scientific leader in fields of immunology, innate immunity and inflammasomes at the School of Medicine at the University of North Carolina-Chapel Hill. IMMvention has been funded by private venture capital, North Carolina Biotechnology Center, NIH SBIR grants/contracts, and Pharma collaborations.